© 2016 TransBCR

Images courtesy of Walter and Eliza Hall Institute

Accelerating the translation of laboratory research
to improved treatments for breast cancer patients

 

The Centre for Translational Breast Cancer Research (TransBCR) is a collaborative group of researchers from several Australian hospitals and research institutes.

By coupling laboratory and clinical breast cancer research we aim to enable world-class research discoveries to rapidly translate to optimal care for patients with breast cancer.
 
TransBCR is housed within the Walter and Eliza Hall Institute for Medical Research through core funding from a National Health and Medical Research Council Centre of Research Excellence grant.

Latest News

October 22, 2019

PALVEN clinical trial opens it's doors at Peter Mac and Royal Melbourne Hospitals

A new clinical trial assessing the use of a triple combination therapy in advanced metastatic breast cancer - PALVEN - has opened today, and is recruiting patients at the Peter MacCallum Cancer Centre and the Royal Melbourne Hospital.

 

For more information contact transbcr@wehi.edu.au​ 

October 01, 2019

The international breast cancer prevention trial 'BRCA-P' officially opens!

Today sees the official launch of the "BRCA-P" clinical trial being led in Australia by Breast Cancer Trials. This is the first global clinical trial that aims to prevent breast cancer in women with the BRCA1 gene mutation. Read more...

TransBCR will oversee the BRCA-P trial at the Peter Mac and Royal Melbourne Hospitals

July 31, 2019

Upcoming BRCA-P study making headlines

BRCA-P, an international breast cancer prevention study for women that have the BRCA1 mutation, will shortly be opening its doors in Australia. The study sponsored nationally by Breast Cancer Trials will see its lead site opened through the Centre for Translational Breast Cancer Research (TransBCR) in Melbourne in the coming months.

More information about the trial is available here

For recent media coverage see The Age

December 07, 2018

TransBCR's m-BEP study finds novel treatment combination brings new breast cancer hope

In a world first, breast cancer researchers at The Royal Melbourne Hospital, Peter MacCallum Cancer Centre and The Walter and Eliza Hall Institute of Medical Research, have successfully combined a drug used to treat chronic leukaemia with therapy used to treat breast cancer. The findings were published in the journal Cancer Discovery.

[Reproduced with permission from Melbourne Health]

Read more.....